Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SUN PHARMA ALKEM LABORATORIES/
SUN PHARMA
 
P/E (TTM) x 37.5 43.2 86.8% View Chart
P/BV x 6.5 6.9 94.1% View Chart
Dividend Yield % 1.0 0.7 142.6%  

Financials

 ALKEM LABORATORIES   SUN PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
SUN PHARMA
Mar-23
ALKEM LABORATORIES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,6251,072 338.2%   
Low Rs2,835790 359.0%   
Sales per share (Unadj.) Rs970.1182.9 530.4%  
Earnings per share (Unadj.) Rs84.235.7 236.0%  
Cash flow per share (Unadj.) Rs110.246.2 238.3%  
Dividends per share (Unadj.) Rs50.0011.50 434.8%  
Avg Dividend yield %1.51.2 125.3%  
Book value per share (Unadj.) Rs756.4233.4 324.1%  
Shares outstanding (eoy) m119.572,399.34 5.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.35.1 65.4%   
Avg P/E ratio x38.426.1 147.0%  
P/CF ratio (eoy) x29.320.1 145.6%  
Price / Book Value ratio x4.34.0 107.1%  
Dividend payout %59.432.2 184.2%   
Avg Mkt Cap Rs m386,2072,233,361 17.3%   
No. of employees `000NANA-   
Total wages/salary Rs m21,31482,960 25.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,993438,857 26.4%  
Other income Rs m2,1618,199 26.4%   
Total revenues Rs m118,153447,055 26.4%   
Gross profit Rs m15,065112,900 13.3%  
Depreciation Rs m3,10425,294 12.3%   
Interest Rs m1,0741,720 62.4%   
Profit before tax Rs m13,04894,084 13.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9808,476 35.2%   
Profit after tax Rs m10,06885,608 11.8%  
Gross profit margin %13.025.7 50.5%  
Effective tax rate %22.89.0 253.5%   
Net profit margin %8.719.5 44.5%  
BALANCE SHEET DATA
Current assets Rs m86,064398,619 21.6%   
Current liabilities Rs m37,071199,064 18.6%   
Net working cap to sales %42.245.5 92.9%  
Current ratio x2.32.0 115.9%  
Inventory Days Days33147 22.2%  
Debtors Days Days6795 70.5%  
Net fixed assets Rs m37,245376,960 9.9%   
Share capital Rs m2392,399 10.0%   
"Free" reserves Rs m90,208557,555 16.2%   
Net worth Rs m90,447559,954 16.2%   
Long term debt Rs m00-   
Total assets Rs m124,541775,794 16.1%  
Interest coverage x13.255.7 23.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 164.6%   
Return on assets %8.911.3 79.5%  
Return on equity %11.115.3 72.8%  
Return on capital %15.617.1 91.3%  
Exports to sales %14.60-   
Imports to sales %00-   
Exports (fob) Rs m16,916NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m16,916154,053 11.0%   
Fx outflow Rs m4,19071,511 5.9%   
Net fx Rs m12,72782,541 15.4%   
CASH FLOW
From Operations Rs m16,82549,593 33.9%  
From Investments Rs m1,128-79,437 -1.4%  
From Financial Activity Rs m-17,60823,761 -74.1%  
Net Cashflow Rs m4161,155 36.0%  

Share Holding

Indian Promoters % 56.7 54.5 104.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 36.6 66.7%  
FIIs % 8.5 17.1 49.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 45.5 95.0%  
Shareholders   65,184 612,626 10.6%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on ALKEM LABORATORIES vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Sun Pharma Share Price Performance

Period ALKEM LABORATORIES Sun Pharma S&P BSE HEALTHCARE
1-Day -1.18% 0.77% 1.18%
1-Month -0.99% 3.00% -0.75%
1-Year 52.26% 64.65% 61.82%
3-Year CAGR 21.70% 39.45% 18.16%
5-Year CAGR 22.99% 27.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.